Journal
AGING CLINICAL AND EXPERIMENTAL RESEARCH
Volume 29, Issue 1, Pages 81-88Publisher
SPRINGER
DOI: 10.1007/s40520-016-0716-1
Keywords
Physical function; Aging; Prevention; Skeletal muscle; Disability
Categories
Funding
- Innovative Medicines Initiative-Joint Undertaking [IMI-JU115621]
- Centro Studi Achille e Linda Lorenzon
- Fondazione Roma
- Catholic University of the Sacred Heart
- European Federation of Pharmaceutical Industries and Associations (EFPIA)
Ask authors/readers for more resources
In the present article, the rationale that guided the operationalization of the theoretical concept of physical frailty and sarcopenia (PF&S), the condition of interest for the Sarcopenia and Physical Frailty in Older People: Multicomponent Treatment Strategies (SPRINTT) trial, is presented. In particular, the decisions lead to the choice of the adopted instruments, and the reasons for setting the relevant thresholds are explained. In SPRINTT, the concept of physical frailty is translated with a Short Physical Performance Battery score of >= 3 and <= 9. Concurrently, sarcopenia is defined according to the recent definitions of low muscle mass proposed by the Foundation for the National Institutes of Health-Sarcopenia Project. Given the preventive purpose of SPRINTT, older persons with mobility disability (operationalized as incapacity to complete a 400-m walk test within 15 min; primary outcome of the trial) at the baseline are not included within the diagnostic spectrum of PF&S.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available